JULIA KROPP: Open Payments
NPI 1427368141 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 44 payments from 11 companies in 2025. Trend: 2023 $1,632 · 2024 $1,238 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $205 |
| Teva Pharmaceuticals USA, Inc. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Axsome Therapeutics, Inc. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 5 | $80 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Alkermes, Inc. | 2 | $57 |
| Indivior Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $45 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: VRAYLAR, Auvelity, REXULTI, COBENFY, UZEDY, FANAPT, ABILIFY ASIMTUFII, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
